Glenmede Trust’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-16,000
| Closed | – | – | 3255 |
|
2019
Q3 | $0 | Hold |
16,000
| – | – | ﹤0.01% | 3256 |
|
2019
Q2 | $0 | Hold |
16,000
| – | – | ﹤0.01% | 3308 |
|
2019
Q1 | $0 | Hold |
16,000
| – | – | ﹤0.01% | 3319 |
|
2018
Q4 | $0 | Sell |
16,000
-28,000
| -64% | – | ﹤0.01% | 3181 |
|
2018
Q3 | $1K | Sell |
44,000
-16,000
| -27% | -$364 | ﹤0.01% | 1420 |
|
2018
Q2 | $21K | Buy |
60,000
+52,000
| +650% | +$18.2K | ﹤0.01% | 1713 |
|
2018
Q1 | $11K | Hold |
8,000
| – | – | ﹤0.01% | 2159 |
|
2017
Q4 | $11K | Sell |
8,000
-1,900
| -19% | -$2.61K | ﹤0.01% | 2159 |
|
2017
Q3 | $22K | Sell |
9,900
-145
| -1% | -$322 | ﹤0.01% | 1932 |
|
2017
Q2 | $21K | Hold |
10,045
| – | – | ﹤0.01% | 1899 |
|
2017
Q1 | $21K | Hold |
10,045
| – | – | ﹤0.01% | 1899 |
|
2016
Q4 | $43K | Buy |
10,045
+2,000
| +25% | +$8.56K | ﹤0.01% | 1654 |
|
2016
Q3 | $38K | Buy |
8,045
+7,900
| +5,448% | +$37.3K | ﹤0.01% | 1714 |
|
2016
Q2 | $0 | Hold |
145
| – | – | ﹤0.01% | 2911 |
|
2016
Q1 | $0 | Buy |
+145
| New | – | ﹤0.01% | 2869 |
|